Questions about COVID-19 and GLP-1 medications are common in the pregnant/postpartum population. Newborn care specialists, who provide in-home infant care and parent education during the postpartum period, can assist families in navigating these topics.

Designed specifically for newborn care specialists, this webinar will help identify some commonly asked questions about COVID-19 and GLP-1 medications, apply communication strategies that support families and their questions while staying within professional scope, and recognize when family questions require referral to healthcare providers.

Chris Stallman, MLS, MS is a certified genetic counselor, Program Director of the University of Arizona Genetic Counseling Graduate Program, and Director of MotherToBaby Arizona. As a teratogen information specialist with MotherToBaby, Chris supports patients, families, and healthcare providers in navigating questions about medications and other exposures during pregnancy and breastfeeding and promotes evidence-based, accessible health information.